Tectonic Therapeutic, Inc. (TECX)
(Delayed Data from NSDQ)
$18.65 USD
+0.18 (0.97%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $18.57 -0.08 (-0.43%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Income Statements
Fiscal Year end for Tectonic Therapeutic, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | -10 | 105 | 119 | 120 | 76 |
Income After Depreciation & Amortization | 10 | -105 | -119 | -120 | -76 |
Non-Operating Income | 2 | 0 | 0 | 1 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 13 | -106 | -119 | -120 | -73 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 12 | -106 | -119 | -120 | -73 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 12 | -106 | -119 | -120 | -73 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11 | -104 | -117 | -119 | -75 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 10 | -105 | -119 | -120 | -76 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 44.57 | 43.74 | 42.85 | 36.21 | 27.43 |
Diluted EPS Before Non-Recurring Items | -1.58 | -2.42 | -2.78 | -3.31 | -2.66 |
Diluted Net EPS (GAAP) | 0.27 | -2.42 | -2.78 | -3.31 | -2.66 |
Fiscal Year end for Tectonic Therapeutic, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 11.42 | 7.94 | 9.66 | 22.93 | -68.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | -11.42 | -7.94 | -9.66 | -22.93 | 68.01 |
Non-Operating Income | -1.22 | 1.13 | 1.25 | 1.36 | -0.53 |
Interest Expense | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -12.67 | -6.81 | -8.41 | -21.58 | 67.48 |
Income Taxes | 0.00 | 0.00 | 0.38 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -12.67 | -6.81 | -8.79 | -21.58 | 67.48 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -12.67 | -6.81 | -8.78 | -21.58 | 67.48 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 2.92 | 44.79 | 44.33 | 44.53 | 44.28 |
Diluted EPS Before Non-Recurring Items | -3.81 | -0.15 | -0.20 | -0.44 | -0.37 |
Diluted Net EPS (GAAP) | -4.34 | -0.15 | -0.20 | -0.48 | 1.52 |